Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Judge wants more details on ex-drug executive Shkreli's finances

Published 06/19/2017, 04:06 PM
Updated 06/19/2017, 04:10 PM
© Reuters. Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, arrives for a hearing at U.S. Federal Court in Brooklyn, New York

By Brendan Pierson

(Reuters) - Former drug company executive Martin Shkreli should reveal more about his finances if he wants his $5 million bail cut to $2 million, a Brooklyn federal judge said Monday, a week before Shkreli is set to face trial on securities fraud charges.

Lawyers for Shkreli, who drew public outrage after raising the price of a life-saving drug 5,000 percent when he was CEO of Turing Pharmaceuticals in 2015, said in a court filing last week that he needed the $3 million to pay back taxes and his lawyers and accountants. Federal prosecutors have not agreed to the request.

U.S. District Judge Kiyo Matsumoto did not rule on Shkreli's request at a hearing on Monday, but said she would be "reluctant" to release the money without knowing more about what assets Shkreli had and what he had done to liquidate them.

Shkreli has pleaded not guilty to criminal charges involving his management of his previous company Retrophin Inc and the hedge fund MSMB Capital Management from 2009 to 2014.

Prosecutors claim that he engaged in a Ponzi-like scheme in which he defrauded investors in MSMB and took millions in assets from Retrophin to repay them. A trial is set to begin next Monday and last at least four weeks.

Alixandra Smith, Assistant U.S. Attorney in Brooklyn, said at Monday's hearing that Shkreli had reported his net worth at $70 million after being arrested.

Shkreli's lawyer, Benjamin Brafman, conceded that Shkreli still owned a share of Turing worth $30 to $50 million, but said he could not sell it without the consent of the other partners in the company.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Smith said the government was skeptical that Shkreli was cash-poor in part because he bragged of his wealth on Twitter and other social media, flaunting purchases like a $2 million Wu-Tang Clan album, a Picasso and a World War II-era Enigma code breaking machine.

Shkreli has also pledged in a Facebook (NASDAQ:FB) post to pay $100,000 for information leading to the arrest of the killer of former Democratic National Committee employee Seth Rich, whose murder has sparked conspiracy theories. He also offered $40,000 to a Princeton student who solved a mathematical proof, Smith said.

Brafman, however, suggested that Shkreli's social media boasting was just a sign of the times.

"Tweeting has become, unfortunately, so fashionable, and when people tweet, they don't always mean what they say," he said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.